Therapeutic Group: Anti Cancer Presentation Calcent 100: Each capsule contains Acalabrutinib INN 100 mg. Description Acalabrutinib is a small-molecule inhibitor of BTK. Acalabrutinib and its active metabolite, ACP-5862, form a covalent bond with a cysteine residue in the BTK active site, leading to inhibition of BTK enzymatic activity. BTK is a signaling molecule of the […]